2.1. Toll-like Receptor 9 (TLR9) Inhibition Attenuates the Phenotypic Manifestations of Arthritis in an Epstein-Barr Virus (EBV) DNA-Exacerbated RA Mouse Model. Here, TLR9 is linked to rheumatoid arthritis.